Live · 24 Oct 2026 SPX 7,623.68 -0.52% NDX 28,957.53 +0.00% VIX 19.45 +2.21% GOLD 4,007.90 -1.29% CL 103.27 +3.82% BTC 80,708.25 -0.74%

Case Studies

Real trades dissected with Titan tools.

Mitsubishi Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass.
· Case Studies, Earnings Echo, Trader Mindset

Mitsubishi Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass.

Earnings Review · 06 August 2026 Mitsubishi Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass. The print Revenue $2151.17B. EPS…

Texas Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass.
· Case Studies, Earnings Echo, Trader Mindset

Texas Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass.

Earnings Review · 06 August 2026 Texas Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass. The print Revenue $5.46B. EPS…

Wells Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass.
· Case Studies, Earnings Echo, Trader Mindset

Wells Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass.

Earnings Review · 06 August 2026 Wells Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass. The print Revenue $22.62B. EPS…

GE Stumbled This Quarter. Why It Still Clears Our Ethical Screen.
· Case Studies, Earnings Echo, Trader Mindset

GE Stumbled This Quarter. Why It Still Clears Our Ethical Screen.

Earnings Review · 06 August 2026 GE Stumbled This Quarter. Why It Still Clears Our Ethical Screen. The print Revenue $11.10B. EPS $2.47 vs $3.18…

AstraZeneca Reported: Clears One of Our Screens, With a Caveat on the Stricter Standard.
· Case Studies, Earnings Echo, Trader Mindset

AstraZeneca Reported: Clears One of Our Screens, With a Caveat on the Stricter Standard.

Earnings Review · 06 August 2026 AstraZeneca Reported: Clears the Faith-Based Screen, With a Caveat on the Broader Standard. The print Revenue $15.38B. EPS $1.32…

Arm Beat and Clears Our Screen, but the Valuation Leaves No Room for Error.
· Case Studies, Earnings Echo, Trader Mindset

Arm Beat and Clears Our Screen, but the Valuation Leaves No Room for Error.

Earnings Review · 06 August 2026 Arm Beat and Clears Our Screen, but the Valuation Leaves No Room for Error. The print Revenue $1.29B. EPS…

Novartis Delivered the Quarter and Clears Our Principled Screen. What We’re Watching.
· Case Studies, Earnings Echo, Trader Mindset

Novartis Delivered the Quarter and Clears Our Principled Screen. What We’re Watching.

Earnings Review · 06 August 2026 Novartis Delivered the Quarter and Clears Our Principled Screen. What We’re Watching. The print Revenue $14.95B. EPS $2.41 vs…

Philip Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass.
· Case Studies, Earnings Echo, Trader Mindset

Philip Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass.

Earnings Review · 06 August 2026 Philip Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass. The print Revenue $11.19B. EPS…

RTX Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass.
· Case Studies, Earnings Echo, Trader Mindset

RTX Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass.

Earnings Review · 06 August 2026 RTX Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass. The print Revenue $24.71B. EPS…

Goldman Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass.
· Case Studies, Earnings Echo, Trader Mindset

Goldman Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass.

Earnings Review · 06 August 2026 Goldman Beat the Quarter, and Still Fails Our Ethical Screen. Here’s Why We Pass. The print Revenue n/a. EPS…

Get our weekly market brief free.